Antibiotics given for the treatment of SAB at any time during treatment, including early empirical treatment (N = 5781).

1Excludes 15/593 patients known to have been treated but information missing on antibiotics received (n = 10) or susceptibility to methicillin (n = 5, all received flucloxacillin).2Of 578 with information on antibiotics received, between 1–4 had missing information on whether they received an antibiotic. Antibiotics other than those listed were given to 81/578 (15%) patients. The most commonly used were a fluoroquinolone (n = 28, 5%) and doxycycline (n = 12, 2%). Daptomycin and tigecycline were used once.3The 4 patients not treated with vancomycin either died (n = 1) or were discharged (n = 3) within 24 hours of the positive blood culture.

1. 本数据集排除15/593名已知接受过治疗，但所使用抗生素信息（n=10）或甲氧西林(methicillin)敏感性信息（n=5，该5名患者均接受氟氯西林(flucloxacillin)治疗）缺失的患者。2. 在具备抗生素用药信息的578名患者中，有1至4名的抗生素用药情况信息存在缺失。另有81/578（15%）的患者使用了表中未列明的抗生素，其中最常用的为氟喹诺酮类(fluoroquinolone)（n=28，占比5%）与多西环素(doxycycline)（n=12，占比2%），达托霉素(daptomycin)与替加环素(tigecycline)各使用1次。3. 4名未接受万古霉素(vancomycin)治疗的患者，均在血培养结果呈阳性后的24小时内发生死亡（n=1）或出院（n=3）。